Genmedica Therapeutics
Barcelona · Founded 2004
About Genmedica Therapeutics
Genmedica Therapeutics is a development-stage biotechnology company focused on type 2 diabetes. They believe that although there are a number of oral drug classes that effectively lower glycemia, in fact, there are currently no good diabetes drugs. Namely, drugs that lower glycemia and are disease modifiers: slowing or halting the progression of the disease. Genmedica Therapeutics was founded in 2004 and is based in Barcelona, Spain.
Company Facts
- Founded: 2004
- Legal name: Genmedica Therapeutics S.L.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $22.7M
- Last round: Series Unknown (Dec 2015)
- Website: genmedica.com
- Phone: +34 932 68 29 91
Canonical: https://fsome.com/organization/genmedica-therapeutics-8393346 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.